Search

Search Constraints

You searched for: Author/Creator Turpie, Alexander G. G.

Search Results

1. Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies. Issue 3 (20th March 2021)

2. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients. (23rd July 2019)

3. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD�AF and treated with vitamin K antagonists. (12th April 2016)

4. Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban. Issue 5 (3rd March 2020)

5. Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD‐VTE. (16th September 2021)

6. Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry. Issue 3 (5th February 2019)

7. Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE. (8th November 2021)

8. Predictive value of venous thromboembolism (VTE)‐BLEED to predict major bleeding and other adverse events in a practice‐based cohort of patients with VTE: results of the XALIA study. (19th August 2018)

9. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE. Issue 2 (20th February 2021)

10. Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry. (23rd July 2021)